Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mineur

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biochimica Et Biophysica Acta|October 4, 2005
RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblastsP Mineur, A Guignandon, Ch A Lambert, et al.
Acta Clinica Belgica|October 7, 2004
Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac diseaseA Sonet, I Théate, M Delos, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
Leukemia|July 1, 1994
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remissionB Filleul, A Delannoy, A Ferrant, et al.
Bone Marrow Transplantation|May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remissionA Ferrant, C Doyen, A Delannoy, et al.
European Journal of Haematology|April 1, 1996
Infectious complications after 2-chlorodeoxyadenosine therapyE Van Den Neste, A Delannoy, B Vandercam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'AdulteM Diviné, E Lepage, J Brière, et al.
Acta Clinica Belgica|December 3, 2014
Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing surveyY Beguin, D Selleslag, S Meers, et al.
Journal of Internal Medicine|June 25, 2009
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric studyDaan Dierickx, G Verhoef, A Van Hoof, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biochimica Et Biophysica Acta|October 4, 2005
RGDS and DGEA-induced [Ca2+]i signalling in human dermal fibroblastsP Mineur, A Guignandon, Ch A Lambert, et al.
Acta Clinica Belgica|October 7, 2004
Clinical and pathological features of 14 non-Hodgkin's lymphomas associated with coeliac diseaseA Sonet, I Théate, M Delos, et al.
Annals of Hematology|March 5, 1998
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemiaE Van Den Neste, P Martiat, P Mineur, et al.
Leukemia|July 1, 1994
A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remissionB Filleul, A Delannoy, A Ferrant, et al.
Bone Marrow Transplantation|May 1, 1995
Karyotype in acute myeloblastic leukemia: prognostic significance in a prospective study assessing bone marrow transplantation in first remissionA Ferrant, C Doyen, A Delannoy, et al.
European Journal of Haematology|April 1, 1996
Infectious complications after 2-chlorodeoxyadenosine therapyE Van Den Neste, A Delannoy, B Vandercam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'AdulteM Diviné, E Lepage, J Brière, et al.
Acta Clinica Belgica|December 3, 2014
Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing surveyY Beguin, D Selleslag, S Meers, et al.
Journal of Internal Medicine|June 25, 2009
Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric studyDaan Dierickx, G Verhoef, A Van Hoof, et al.
Leukemia|October 29, 2004
Translocation t(1;6)(p35.3;p25.2): a new recurrent aberration in "unmutated" B-CLLL Michaux, I Wlodarska, K Rack, et al.
Pageof 4